Form 8-K - Current report:
SEC Accession No. 0001493152-24-047422
Filing Date
2024-11-22
Accepted
2024-11-22 16:48:49
Documents
21
Period of Report
2024-11-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 57424
2 ex1-1.htm EX-1.1 112114
3 ex5-1.htm EX-5.1 22984
4 ex10-1.htm EX-10.1 301898
5 ex10-2.htm EX-10.2 111963
6 ex10-3.htm EX-10.3 105794
7 ex99-1.htm EX-99.1 14165
8 ex5-1_001.jpg GRAPHIC 5068
9 ex99-1_001.jpg GRAPHIC 10995
  Complete submission text file 0001493152-24-047422.txt   1055339

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE indp-20241122.xsd EX-101.SCH 3021
11 XBRL LABEL FILE indp-20241122_lab.xml EX-101.LAB 34240
12 XBRL PRESENTATION FILE indp-20241122_pre.xml EX-101.PRE 24169
23 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3615
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

EIN.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40652 | Film No.: 241490518
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)